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In the UK, the national dementia strategy1 strongly
supports the concept of timely diagnosis and intervention
in dementia. The cost-effectiveness of such services has
been demonstrated.2-6 Studies show that memory services
may improve quality of life for patients and carers.7-9 The
recognition of dementia enables the provision of safer care
by considering, for example, accommodation and care needs
and encouraging advanced decision-making. Reaching a
diagnosis can help patients and carers to tolerate their
symptoms better and suitable treatments can be considered.
Advocates of dedicated ‘memory clinic services’ (MCSs)
point to the benefits of a less stigmatising setting, with a
focus on psychosocial interventions, education and the
promotion of research and clinical governance.5,7,10-14
Opponents are concerned with resources being diverted
from community mental health teams (CMHTs) and point
to higher costs of MCS services.15,16
In this study, Trust A has a dedicated memory clinic
service (henceforth called MCS group) as well as a CMHT.
In Trust B there is a ‘traditional’ CMHT-based service
(henceforth called CMHT group) where referrals of all types
are seen. We compared the costs with those of secondary
care and the quality of the service offered to similar types of
patients referred for a non-urgent diagnostic memory
assessment in these two service models in neighbouring
trusts. Patients were evaluated retrospectively using case-
note review in terms of the cost and quality of care they
received in secondary care for up to 6 months in similar
rural/suburban areas.
Method
Study design
This study was a health service evaluation and used
retrospective data collected routinely as part of the usual
services provided in both trusts, so local research ethics
committee permission was not needed.
Demographic matching
Two rural and suburban eastern areas of England were
matched using data from the Eastern Region Public Health
Observatory (ERPHO). The number of people over the age
of 65 years, based on general practice (GP) records in these
areas, was recorded: 20 289 people in the MCS group and
21 112 people in the CMHT group. Data from the British
primary care Quality and Outcomes Framework (QOF),17
which requires the recording of dementia and other chronic
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Aims and method To compare the cost and quality of a memory-clinic-based
service (MCS) with a traditional community mental health team (CMHT) service.
Using a retrospective case-note review, we studied two groups, each with 33
participants. Consecutive referrals for diagnostic ‘memory’ assessments over 4
months were evaluated. Participants were evaluated for up to 6 months.
Results The MCS was less costly than the CMHTservice but the difference was not
statistically significant (mean cost for MCS was £742, mean cost for CMHT service
was £807). The MCS offered more multidisciplinary and comprehensive care,
including: pre- and post-diagnostic counselling, more systematic screening of blood
for reversible causes of dementia, more use of structured assessment instruments in
patients/carers, signposting to the third sector as well as more consistent copying of
letters to patients/carers.
Clinical implications An MCS service offered more comprehensive and
multidisciplinary service at no extra cost to secondary care.
Declaration of interest None.
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conditions, showed that the prevalence of dementia and
strokes, and the recording of cholesterol and blood pressure,
were similar in both groups. The Indices of Multiple
Deprivation (IMD)18 show that the GP practices in the
CMHT service (Trust B) experienced less deprivation. The
range of the IMD was 11.5-17.7 for the MCS and 5.7-8.96 for
the CMHT service.
Patient identification
We examined all referrals received over the time frame of
the study (4 months) from specific, predetermined GP
practices in these two rural/suburban areas. All patients
included in the study had to fulfil Department of Health
memory clinic referral criteria.19 These criteria state that
memory services will see all patients with subjective
memory problems or change in everyday function, or a
carer’s report of change in a patient over a period of more
than 6 months. Patients referred should have no previous or
definitive diagnosis of dementia. The Department of Health
stipulates that memory services will not see patients where
urgent treatment is needed, for example those with more
complex behavioural and psychological problems, patients
with suicidal ideation, psychotic behaviour or a crisis
situation from the carer’s perspective. Patients with early-
onset dementia (age under 64 years) were also excluded
because the two areas have different referral pathways for
such patients. The MCS service received two referrals of
early-onset dementia, which were excluded from this study;
there were no such referrals in the CMHT service. All
referrals had to have been received between August and
November 2011 in both services.
For the MCS group, a computerised search of all
memory clinic patients referred by GP practices in the
designated area of the trust was performed for the specified
time period. Thirty-four consecutive patients were
identified and all fulfilled the Department of Health
memory clinic criteria.19 One patient refused the diagnostic
interview after pre-diagnostic counselling and that patient
was excluded. Occasionally, patients may be passed on to
the crisis team or CMHT, but none on our list had been
dealt with in this way.
For the CMHT group, a member of the research team
(M.J.V.R.) manually searched all consecutive referrals to the
service from particular GP practices from a central written
database. Thirty-three referrals were included in the CMHT
group (by coincidence, the same number of patients as the
MCS group). These 33 patients all fulfilled Department of
Health memory clinic criteria19 and were identified by
consecutively recruiting from the original list. Patients were
excluded only if they did not fulfil memory clinic criteria.19
A second member of the research team (J.S.R.) ensured that
all referrals met these criteria for inclusion or exclusion.
There was uncertainty as to whether to include one patient
and a senior nurse’s opinion from the MCS team was sought
to arbitrate.
Questionnaires
Quality of service
A data extraction sheet to assess the quality of the service
was developed for this study. It was used for case-note
analysis and captured information routinely collected by
clinicians for assessment purposes (Box 1). The quality
criteria were chosen based on the National Institute for
Health and Care Excellence (NICE) guidance for dementia
services,20 the Memory Services National Accreditation
Programme (MSNAP) criteria where they could be applied
to both services,21 and literature evidence.10,11,22 We
pragmatically assessed whether the data could be extracted
retrospectively from the services. This information was
obtained from computerised and handwritten notes from
the initial contact with the patient and for the following 6
months of contact with the mental health service. The
psychiatrists involved in the data collection conferred about
any uncertainties with recording of data. M.J.V.R. and Z.A.-S.
each initially screened at least four sets of case records
together with J.S.R. to ensure interrater reliability in
recording of data. All entries were scrutinised by J.S.R. to
ensure data entry was consistent. Any missing information
was noted. It is the view of clinicians in both trusts that GPs
are best suited to conduct physical examinations and these
are stated in the requirements for referral to the service by
the MCS trust. However, individual psychiatrists often
choose to conduct some aspects of the physical examination
themselves and the extent to which clinicians were doing
this was noted.
Cost of service
The Client Service Receipt Inventory (CSRI)23 was adapted
for this study (available from the authors on request). This
includes all the mental health service costs for each
individual patient from the initial point of contact and
then all subsequent contacts with the mental health service
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Box 1 Measures extracted regarding the quality of the
memory service
. Background characteristics (age, gender, marital status,
employment, school-leaving age, accommodation)
. Waiting time to be seen
. Symptom time prior to referral
. Presence of a carer, relative, friend
. Pre-diagnostic counselling
. Dementia blood screen: ordered, examined
. Informal assessment of functioning, behaviour, depression,
global assessment
. Structured questionnaires to assess functioning, behaviour,
global assessment
. Brain imaging
. Physical examination (record from GP/psychiatrist)
. MMSE, ACE-R or other cognitive tools utilised
. Record of a diagnosis
. Record of risk assessment
. Record of post-diagnostic advice to patient/carer
. Record of discussion about driving
. Copying of letters to patients/carers
ACE-R, Addenbrooke’s Cognitive Examination-Revised; GP, general
practitioner; MMSE, mini-Mental State Examination.
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over the following 6 months. Costing stopped at the point
the patient was discharged back to the GP. However,
patients found to need more extensive follow-up for more
severe or complex behavioural and psychological symptoms
of dementia (BPSD) were referred to the CMHT service in
Trust A (one patient) and Trust B (three patients). Costs
were excluded from that point. Costing was calculated from
the perspective of National Health Service care24
(secondary care only evaluated in this study) rather than
from a wider medical or societal perspective. Costs for
hourly contact with professionals were mainly derived from
the unit costs for health and Social Services compendium
and included ‘on costs’, for example for a consultant
psychiatrist this includes salary, national insurance and
superannuation, qualifications, overheads, ongoing training
and capital overheads.25 From this document,25 the cost per
hour for consultant time is £162 (including on costs such as
administrative support and buildings) and the cost per hour
for a non-medical clinician (e.g. CMHT nurse) is £44. The
costs of drugs prescribed by secondary care were derived
from the British National Formulary.26 The costs of scans
were derived on the basis of the Department of Health’s
Dementia Commissioning Pack.27 Costs incurred as a result
of time spent on discussion and meetings were based on the
size of individual teams, allowing for an average of 6min
discussion per patient (team sizes and calculations available
from the author). The average time taken for domiciliary
visit and/or administrative time costs were calculated on
the basis of discussions with representatives from
professional groups in each of the teams or on data
recorded by team members (average times for appointment
available from the author on request). The mileage travelled
by clinicians was calculated using the Automobile Associa-
tion Website (www.theaa.com). Travel and transport costs
are part of general overheads in the unit costs of health and
social care,25 but as this was anticipated to be an area of
difference between the two models, this was calculated
separately for each patient seen at the rate of 54p/mile up to
3500 miles as suggested in this unit cost document.
Analysis
Data were analysed using Excel 2007 and Stata Version 12.1
for Windows (w2, Fisher’s exact tests if less than 5 in a cell,
Wilcoxon rank sum test). Parametric and non-parametric
tests were applied, as appropriate, to evaluate costs and
quality of care provided. To be conservative and because
non-parametric distributions were predicted, the cost data
were analysed using the Wilcoxon rank sum test.
Results
Quality data
A similar range of diagnoses were seen in both areas
(Alzheimer’s or mixed dementia: 17 in MCS group, 15 in
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Table 1 Demographic data and results of assessment in memory clinic service (MCS) group and community mental
health team (CMHT) group
MCS
group
(n= 33)a
CMHT
group
(n= 33)a P Comments
Mean age, years 80 84 0.03 Significantly older in Trust B
Mean age when leaving school, years 15 15 40.05 Not recorded in 4 patients in MCS and in
20 patients in CMHT
Female, n (%) 19 (58) 22 (67) 40.05
MMSE, median 23.5 25 0.2 n=32 in both groups
ACE-R, median (range) 67 (76) CMHT group not analysed as only 9 patients
had ACE-R done, n= 31 in MCS group
Accommodation - independent/
sheltered, n (%)
32 (97) 30 (94) 40.05
Seen with relative/friend/carer, n (%) 33 (100) 24 (73) 50.001 Clinicians in CMHT group may have
contacted relative by telephone after interview
Mean days to be seen (s.e.), n (%) 25 (3) 20 (3) 0.23
Mean months since symptom onset 23 24 0.77 12 not known in CMHT group
Received pre-diagnostic counselling, n (%) 32 (94) 2 (6) 50.0001
Dementia blood screen examined, n (%) 33 (100) 24 (73) 0.001
Physical exam done by GP/psychiatrist, n (%) 16 (48) 14 (42) n/s
Functioning examined formally, n (%) 24 (73) 1 (3) 50.0001 e.g. Bristol Activities of Daily Living30
Behaviour examined formally, n (%) 22 (67) 1 (3) 50.0001 e.g. Cambridge Behavioural Inventory31
Global assessment formal, n (%) 33 (100) 14 (42) 50.0001 e.g. HoNOS,32 EQ-5D-5L33
Depression examined formally, n (%) 2 (6) 1 (3) 40.05 e.g. Geriatric Depression Scale34
Risk assessment, n (%) 31 (94) 22 (67) 0.02
Patient/carer sent copy of GP letter, n (%) 29 (88) 14 (42) 50.0001
ACE-R, Addenbrooke’s Cognitive Examination-Revised; GP, general practitioner; HoNOS, Health of the Nation Outcome Scales; MMSE, mini-Mental State Examination;
n/s, non-significant.
a. Unless otherwise stated.
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CMHT group; vascular dementia: 9 in MCS and 8 in CMHT;
Lewy body dementia: 0 in MCS group, 2 in CMHT group;
mild cognitive impairment: 6 in both groups; depression: 0
in MCS and 1 in CMHT; other diagnoses: 1 chronic subdural
in MCS group and 1 multiple sclerosis-related cognitive
impairment in CMHT group). Demographic data and the
analysis of data collected during patient assessments are
shown in Table 1.
Diagnostic assessments included a clinical assessment
of behaviour, functioning and a global assessment of
severity in nearly all patients, with no significant differences
between groups on these variables. Some structured
questionnaires (e.g. EQ-5D,33 Cambridge Behavioural
Inventory31) were sent to patients and carers before the
actual appointment in the MCS group. Others were
administered by clinicians during the clinic appointment.
However, structured assessments in patients and carers
using symptom rating scales in these domains were not
routinely done in the CMHT group. A Mini-Mental State
Examination (MMSE)28 was performed in all patients
except one in each group. In the MCS group, the
Addenbrooke’s Cognitive Examination-Revised (ACE-R)
test29 was performed routinely, with a median score of 67,
but it was not performed routinely in the CMHT group.
Computed tomography head scans were ordered as part of
the assessment to a similar extent in both groups (19 in
MCS and 17 in CMHT), whereas scans that had been done
previously and considered by the clinician to be recent
enough to be helpful amounted to a further 6 in the MCS
and 5 in the CMHT group. So, only 8 MCS (24%) and 11
CMHT (33%) patients did not have scans available for
diagnostic purposes. Scanning is widely available in both
trusts and it was patient preference and some clinician
guidance that determined whether a patient had a scan or
not. Diagnoses were recorded by clinicians in 100% of
letters sent to GPs. A psychologist saw two patients in the
MCS group (one for neuropsychological testing and one for
cognitive stimulation therapy) and two patients in the
CMHT group had further neuropsychological testing.
The post-diagnostic advice given by clinicians to
patients and/or carers from the MCS v. CMHT group in
percentage terms was signposting: to the third sector (70%
v. 24%; P = 0.0002); for welfare benefits (55% v. 36%;
P40.05); to Social Services (67% v. 48%; P40.05); advanced
planning discussions (55% v. 45%; P40.05). Interviewers
were better at documenting whether patients were drivers
in the MCS group (information not recorded in three
patients in the MCS group and nine patients in the CMHT
group). Anti-dementia drugs were prescribed in 65% of
patients eligible for prescriptions (if patients had
Alzheimer’s disease, mixed dementias or Lewy body
dementia and MMSE scores greater than 10). Payment
methods differed between groups, with the CMHT passing
on prescribing to GPs after 1-2 months compared with the
MCS group, where clinicians continued to prescribe for 3-4
months.
Patient pathways
The major significant difference was that just under half of
patients in the CMHT group (n = 15, 45%) were seen only by
a doctor at their usual place of residence and then
discharged, whereas in the MCS group 97% were seen by
both a doctor and a non-medical clinician (once or twice).
In the CMHT group, 55% of patients were seen by non-
medical clinicians several times (range 2–11). Although
some patients received no follow-up in the CMHT group,
others received extensive follow-up within the 6-month
period, incurring increased travel time, mileage and face-to-
face costs. Most medical input was from the clinic base for
the MCS group, but 85% of patients also received a
domiciliary visit by a non-medical clinician either pre- or
post-diagnosis (or both).
Costs of service
The total costs per person to secondary care between the
MCS and the CMHT groups over 6 months were not
significantly different in the non-adjusted analysis or the
analysis adjusted for age and MMSE score. The mean total
cost of care in the MCS group was £742 (median £722) and
in the CMHT group it was £807 (median £833). Travel costs
were significantly higher in the CMHT group where all
patients were seen at their usual place of residence
(Z =75.14, P50.0001, effect size 70.63). Consultants
travelling to see patients would often add a cost of £162/
hour to each assessment in the CMHT group. This expense
was not needed for clinic-based assessments by consultants
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Table 2 Mean costs in memory clinic service (MCS) group and community mental health team (CMHT) groupa
Costs MCS group » (mean per person +s.d.) CMHT group» (mean per person +s.d.)
Total Costs 742 (250) 807 (375)
Direct costs 271 (82) 252 (124)
Office costs 182 (81) 224 (130)
Travel timeb 76 (59) 186 (106)
Mileage costs 28 (21) 32 (31)
Multidisciplinary team costs 44 (15) 30 (41)
Scan costs 74 (67) 69 (72)
Drug costs 67 (103) 12 (31)
Bold denotes significance.
a. Small differences in the total means can be accounted for by rounding off.
b. The only significant difference between the groups was in the travel time costs P50.0001; z=75.14 (Wilcoxon rank sum test). The drug, scan and multidisciplinary
team costs were not formally analysed as their distributions were not suitable for parametric testing and there were too many ties for the Wilcoxon rank sum test.
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in the MCS group. The costs for non-medical staff to travel
to see patients more frequently than in the MCS group
also added to this overall travel cost figure. Other
costs between groups were not significantly different using
non-parametric analysis (Table 2).
Discussion
This paper highlights the cost and quality differences
between two service models for patients referred with
concerns about their memory. The total costs to secondary
care were less with the MCS-based service than the CMHT-
based service (median cost of £722 v. £833 per patient), but
this difference was not statistically significant. The MCS
offered significantly more multidisciplinary care to a greater
number of patients than the CMHT service. Both services
offered a high-quality diagnostic service but we argue that
the MCS service was able to offer more systematic and
comprehensive care, including pre-diagnostic counselling,
more systematic screening of blood tests for reversible
causes of dementia/comorbidity, more extended cognitive
examination and structured assessment tools, better
evidence of signposting to the third sector as well as
copying of letters to patients and carers. It has been
demonstrated that there is greater satisfaction with
multidisciplinary assessment35,36 where diagnostic and
management options are explained to both patient and
caregiver.
It is possible that patients in the CMHT group were not
typical for an MCS or that a selection bias was introduced,
with only 33 patients in the CMHT group. However, we feel
this is unlikely as the Department of Health memory clinic
criteria were applied to all referrals accepted into the study
in a systematic way.
We acknowledge that the numbers included in the
study were small and the findings can only be regarded as
preliminary. However, we cannot exclude the possibility
that a CMHT service may be more economical for all types
of patients as it was beyond the scope of this study to
examine the costs for all patients entering CMHT services
in both areas. The study was also not a full economic
evaluation where costs and outcome data (such as delays to
institutional care) are combined to reach conclusions. The
CSRI23 as adapted for this study only examines costs to
secondary mental healthcare and not primary care, social
care or carer time costs. Using the CSRI, we detailed the
patient’s involvement with doctors and other clinicians as
accurately and comprehensively as possible. In real life,
clinicians do not return to base between patient visits so
costs may have been inflated in both services for travel time.
We were aware that there seemed to be differences between
groups in the rate whereby prescribing was handed over
to GPs.
This was a retrospective service evaluation and we
encountered many of the pitfalls of examining data that
were not specifically collected for research purposes.
However, the pragmatic design of this study also means it
is more reflective of actual practice and therefore less
subject to a Hawthorne effect.
Stakeholder views had been sought in both trusts and
satisfaction was high with both services in the year of the
study, but this was not evaluated specifically in this research
and satisfaction cannot be inferred from these data.
There will, of course, be differences among clinicians
about what determines the quality of a memory service and
we acknowledge our own subjectivity. However, we took a
pragmatic view on which variables to include, based on the
literature and the information we were likely to be able to
obtain from retrospective data in these two services. Other
quality indicators for a memory service may be helpful to
consider in future studies, for example the rate of reversible
causes found, the rate of ‘no diagnosis’ made, the range of
diagnoses or the rate at which drugs were accepted by
eligible patients. However, this sample was too small to find
significant between-group differences on these indicators.
The IMD in the MCS group was lower than in the
CMHT group. This could possibly influence referral patterns
but we acknowledge that this is a complex issue, involving
the attitudes of patients, families and their referring GPs.
Ethnicity was not specifically matched for in this study and
this is acknowledged as a study limitation. We acknowledge
that both groups had higher than expected rates of patients
not receiving anti-dementia drugs. Clinicians did not always
offer the drug, because they were concerned patients would
not comply with taking the medication. However, some
patients refused the drugs because of possible side-effects or
other factors.
Another emerging care model in the UK utilises the
services of ‘allied mental health professionals’ in making
diagnoses and offering interventions with medical input not
provided face to face for most patients.5,37,38 It may be
argued that some of the diagnostic quality provided by a
‘medical’ view on diagnosis may be compromised in such
services and this needs further evaluation.
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